Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Sites: CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)

NCT05593770 is registered in ClinicalTrials.gov with NEAT ID Foundation as lead sponsor.

NCT NCT05593770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05593770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Sites: CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)
Lead sponsor
NEAT ID Foundation
Phase
Phase 2/3
Overall status
Terminated
Start date
October 27, 2022
Completion date
December 14, 2023
Enrollment
28 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid-19, sars-cov2 infection